ABOUT ELITE
PRODUCTS
PIPELINE
- Generic
- Branded
TECHNOLOGY
INVESTOR RELATIONS

HOME | CAREERS | CONTACT | NEWS |

Skip to content

About Elite
Products
Pipeline
- Generic
- Branded
Technology
Investor Relations

Press Releases

Select:

Nov 06, 2019 Elite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss Second Quarter 2020 Financial Results on November 13, 2019

Sep 12, 2019 Elite Pharmaceuticals Receives FDA Approval for Codeine and Acetaminophen Combo

Aug 11, 2019 Elite Pharmaceuticals, Inc. Reports Financial Results for the First Quarter of Fiscal Year 2020 Ended June 30, 2019 and Provides Conference Call Information

Aug 07, 2019 Elite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss First Quarter 2020 Financial Results on August 12, 2019

Jun 28, 2019 Elite Pharmaceuticals Announces Commercial Launch of Dantrolene Capsules with Marketing Partner Lannett Company

Jun 21, 2019 Elite Pharmaceuticals, Inc. Reports Financial Results for the Fiscal Year Ended March 31, 2019 and Provides Conference Call Information

Jun 14, 2019 Elite Pharmaceuticals, Inc. Delays Fourth Quarter and Year End 2019 Earnings Release Date and Conference Call

Jun 11, 2019 Elite Pharmaceuticals, Inc. to Host Conference Call to Provide Corporate Update and Discuss Year-end Financial Results on June 17, 2019

Mar 11, 2019 Elite Pharmaceuticals Enters into Strategic Marketing Alliance with Lannett For Generic Adderall®

Feb 11, 2019 Elite Pharmaceuticals, Inc. Reports Financial Results for the Third Quarter of Fiscal Year 2019 Ended December 31, 2018 and Provides Conference Call Information

1 2 3 4 5 6 7 8 9 10 11

<< < > >>

Site Map | Privacy | Terms Of Use

Copyright © Elite Pharmaceuticals Inc. | All Rights Reserved.

ART™: Abuse-Resistant Technology for a safer healthier you.

Resize Viewer - Reduce

Resize Viewer - Expand